Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05889923 · ClinicalTrials.gov registry record · NA
Training and Evaluation of Ultrasound-Guided Procedures
A NA study, sponsored by Clear Guide Medical.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT05889923: Completed NA study, sponsored by Clear Guide Medical.
NCT05889923 is a NA study that has completed, run by Clear Guide Medical. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05889923, a NA study, has completed, sponsored by Clear Guide Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
38 certified registered nurse anesthetist (CRNA) students will learn 5 different ultrasound-guided regional anesthesia blocks both with and without a novel device, the EDU which gives the student help finding the right needle path.
Primary Outcome
how close did the student come to the instructor-specified target
Interventions
- DEVICE With EDU
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2021-08-16 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
What the finished NCT05889923 record still lists
NCT05889923 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which With EDU is the first listed.
NCT05889923 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05889923 about?
NCT05889923 is a clinical study titled "Training and Evaluation of Ultrasound-Guided Procedures". 38 certified registered nurse anesthetist (CRNA) students will learn 5 different ultrasound-guided regional anesthesia blocks both with and without a novel device, the EDU which gives the student help finding the right needle path.
What is the current status of trial NCT05889923?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2021-08-16. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT05889923?
The interventions under investigation include: With EDU (DEVICE).
Who is sponsoring clinical trial NCT05889923?
This trial is sponsored by Clear Guide Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05889923's enrollment target sits among peer trials
38 1538th of 2000 higher than 461 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI